Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03661021 · ClinicalTrials.gov registry record
Study of the Ability of a New Technique to Effectively Diagnose Movement Disorders
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 40
- Enrollment target
NCT03661021: Completed study, sponsored by The Cleveland Clinic.
NCT03661021 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03661021 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
Sante Fe is an investigation of a new technique to distinguish between different types of movement disorders, specifically organic versus functional, by observing changes in involuntary movements in two different situations.
Primary Outcome
Change in Simplified Functional Movement Disorders Rating Scale (sFMDRS) score according to video raters between two conditions in FMD vs OrgMD patients. Score reports total abnormal movement score ranging from 0-3 for 9 different regions of the body or body functions. Higher score implies more severe movement.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-07-18 |
| Est. Completion | 2024-07-22 |
What the finished NCT03661021 record still lists
NCT03661021 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03661021 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03661021 about?
NCT03661021 is a clinical study titled "Study of the Ability of a New Technique to Effectively Diagnose Movement Disorders". Sante Fe is an investigation of a new technique to distinguish between different types of movement disorders, specifically organic versus functional, by observing changes in involuntary movements in two different situations.
What is the current status of trial NCT03661021?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2018-07-18. Estimated completion is 2024-07-22.
Who is sponsoring clinical trial NCT03661021?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI